Latest

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

0.9 % w/v Sodium Chloride Injection BP PA0179/002/013

Sodium chloride

B. Braun Medical Limited

Marketed

0.9% Sodium Chloride Intravenous Infusion Solution PA1968/018/001

Sodium chloride

Laboratoire Aguettant

Not marketed

1% w/v Lidocaine Hydrochloride Injection BP PA0736/044/001

Lidocaine Hydrochloride Monohydrate

B. Braun Melsungen AG

Marketed

10 mg/ml Solution for infusion EU/1/19/1383/001-002

Lacosamide

UCB Pharma S.A.

—

100 units/mL Tempo Pen solution for injection in pre-filled pen EU/1/20/1422/016-017

Insulin lispro

Eli Lilly Nederland B.V.

—

2% w/v Lidocaine Hydrochloride Injection BP PA0736/044/002

Lidocaine Hydrochloride Monohydrate

B. Braun Melsungen AG

Marketed

200 units/mL KwikPen solution for injection in pre-filled pen EU/1/20/1422/013-015

Insulin lispro

Eli Lilly Nederland B.V.

—

5% Glucose Intravenous Infusion Solution PA1968/019/001

Glucose

Laboratoire Aguettant

Not marketed

8.4% w/v Sodium Bicarbonate Intravenous Infusion BP PA0179/006/001

Sodium bicarbonate

B. Braun Medical Limited

Marketed

A.Vogel Uva-ursi & Echinacea Cystitis oral drops TR2309/021/001

A.Vogel Ireland Limited

Marketed

Abacavir/Lamivudine Mylan 600 mg/300 mg film-coated tablets PA0577/193/001

Abacavir, Lamivudine

McDermott Laboratories Ltd., T/A Gerard Laboratories

Not marketed

Abacavir/Lamivudine Viatris 600 mg/300 mg Film-coated Tablets PA23266/056/001

Abacavir sulfate, Lamivudine

Viatris Limited

Marketed

ABASAGLAR 100 units/mL solution for injection in a cartridge EU/1/14/944/001-004

Insulin glargine

Eli Lilly Nederland B.V.

—

ABASAGLAR 100 units/mL solution for injection in a pre-filled pen EU/1/14/944/005-008

Insulin glargine

Eli Lilly Nederland B.V.

—

Abecma 260 - 500 x 106 cells dispersion for infusion EU/1/21/1539/001

Idecabtagene Vicleucel

Bristol-Myers Squibb Pharmaceuticals uc

—

Abendur 2.5 mg tablets PA23163/004/001

Bendroflumethiazide

Ascot Laboratories (Ireland) Limited

—

Abendur 5 mg tablets PA23163/004/002

Bendroflumethiazide

Ascot Laboratories (Ireland) Limited

—

Abevmy 25 mg/mL concentrate for solution for infusion EU/1/20/1515/001-005

Bevacizumab

Biosimilar Collaborations Ireland Limited

—

Abidec Multivitamin Oral Drops Solution PA1186/001/001

Ergocalciferol, Thiamine hydrochloride, Riboflavin sodium phosphate, Pyridoxine hydrochloride, Nicotinamide

Chefaro Ireland DAC

Marketed

Abilify 1 mg/mL oral solution EU/1/04/276/033-035

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify 10 mg orodispersible tablets EU/1/04/276/024-026

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify 10 mg tablets EU/1/04/276/006-010

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify 15 mg orodispersible tablets EU/1/04/276/027-029

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify 15 mg tablets EU/1/04/276/011-015

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify 30 mg orodispersible tablets EU/1/04/276/030-032

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify 30 mg tablets EU/1/04/276/016-020

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify 5 mg tablets EU/1/04/276/001-005

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify 7.5 mg/mL solution for injection EU/1/04/276/036

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection EU/1/13/882/001,003

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection EU/1/13/882/002,004

Aripiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify Maintena 720 mg prolonged-release suspension for injection in pre-filled syringe EU/1/13/882/009

Aripiprazole Monohydrate

Otsuka Pharmaceutical Netherlands B.V.

—

Abilify Maintena 960 mg prolonged-release suspension for injection in pre-filled syringe EU/1/13/882/010

Aripiprazole Monohydrate

Otsuka Pharmaceutical Netherlands B.V.

—

Abiraterone 500 mg film-coated tablets PA0711/304/002

Abiraterone acetate

Not marketed

Abiraterone Accord 250 mg tablets EU/1/20/1512/001

Abiraterone acetate

Accord Healthcare S.L.U.

—

Abiraterone Accord 500 mg film-coated tablets EU/1/20/1512/002-003

Abiraterone acetate

Accord Healthcare S.L.U.

—

Abiraterone Aristo 250 mg tablets PA1983/008/001

Abiraterone acetate

Aristo Pharma GmbH

Not marketed

Abiraterone Aristo 500 mg film-coated tablets PA1983/008/002

Abiraterone acetate

Aristo Pharma GmbH

Marketed

Abiraterone AshCure 250 mg film-coated tablets PA25251/001/001

Abiraterone acetate

AshCure Pharma B.V.

Not marketed

Abiraterone AshCure 500 mg film-coated tablets PA25251/001/002

Abiraterone acetate

AshCure Pharma B.V.

Not marketed

Abiraterone Clonmel 500 mg film-coated tablets PA0126/336/001

Abiraterone acetate

Clonmel Healthcare Ltd

Marketed

Abiraterone Krka 500 mg film-coated tablets EU/1/21/1553/001-003

Abiraterone acetate

KRKA, d.d., Novo mesto

—

Abiraterone Mylan 1000 mg film-coated tablets EU/1/21/1571/009-012

Abiraterone acetate

Mylan Pharmaceuticals Limited

—

Abiraterone Mylan 500 mg film-coated tablets EU/1/21/1571/001-008

Abiraterone acetate

Mylan Pharmaceuticals Limited

—

Abiraterone Rowa 500 mg Film-coated tablets PA0074/092/001

Abiraterone acetate

Rowa Pharmaceuticals Limited,

Marketed

Abiraterone Teva 500 mg film-coated tablets PA1986/103/001

Abiraterone acetate

Marketed

Abraxane 5 mg/ml powder for dispersion for infusion EU/1/07/428/001

Paclitaxel

Bristol-Myers Squibb Pharma EEIG

—

Abrysvo powder and solvent for solution for injection EU/1/23/1752/007-009

Respiratory syncytial virus, subgroup A, stabilized prefusion F protein 847A, Respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B

Pfizer Europe MA EEIG

—

Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant) EU/1/23/1752/001-006

Respiratory syncytial virus, subgroup A, stabilized prefusion F protein 847A, Respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B

Pfizer Europe MA EEIG

—

Abseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/1-2

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Abseamed 10 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/15-16

Recombinant human erythropoietin alfa

Medice Arzneimittel Putter GmbH & Co. K.G

—

Cite this view

Priya Life Science (2026). Irish Medicines Register. Derived from the HPRA open dataset. Retrieved 22 September 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.